Evaluation of hepatitis B virus screening and reactivation in patients with hematological malignancies receiving rituximab-based chemoimmunotherapy: A single-center retrospective study
Journal of Oncology Pharmacy Practice
Published online on April 29, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionHepatitis B reactivation (HBVr) is a serious problem in patients with B-cell lymphoproliferative neoplasms receiving rituximab-based chemoimmunotherapy. This retrospective study aimed to evaluate the use of hepatitis B virus (HBV) screening ...
IntroductionHepatitis B reactivation (HBVr) is a serious problem in patients with B-cell lymphoproliferative neoplasms receiving rituximab-based chemoimmunotherapy. This retrospective study aimed to evaluate the use of hepatitis B virus (HBV) screening ...